Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Novo Nordisk and United Laboratories Report Major Trial Success
Novo Nordisk and United Laboratories recently partnered to develop a novel triple receptor agonist. This new medication demonstrated substantial weight reduction during a recent clinical trial. UBT251 targets three specific metabolic pathways to promote weight loss simultaneously. The compound produced…